Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Feldman

Showing results (71-80 of 211) with videos related to

Pageof 22
Sort By:
Seminars in Dialysis|February 7, 2008
Indications for stent placement in a dialysis accessRandall L Rasmussen, David Feldman, Gerald Beathard, et al.
Nature|August 28, 2015
Water and climate: Recognize anthropogenic droughtAmir AghaKouchak, David Feldman, Martin Hoerling, et al.
International Journal of Radiation Oncology, Biology, Physics|September 2, 2008
Selenite treatment inhibits LAPC-4 tumor growth and prostate-specific antigen secretion in a xenograft model of human prostate cancerRumi S Bhattacharyya, Bryan Husbeck, David Feldman, et al.
Molecular and Cellular Endocrinology|June 16, 2005
Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activitySrilatha Swami, Aruna V Krishnan, Donna M Peehl, et al.
Bulletin of the Hospital for Joint Disease (2013)|August 24, 2014
Hip dysplasia in the skeletally mature patientRachel Y Goldstein, Ian David Kaye, James Slover, et al.
Anticancer Research|August 5, 2006
Mechanisms of vitamin D-mediated growth inhibition in prostate cancer cells: inhibition of the prostaglandin pathwayJacqueline Moreno, Aruna V Krishnan, Donna M Peehl, et al.
Molecular Cancer Therapeutics|August 25, 2006
Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of actionBryan Husbeck, Rumi S Bhattacharyya, David Feldman, et al.
Vascular Health and Risk Management|June 12, 2010
Heart rate control with adrenergic blockade: clinical outcomes in cardiovascular medicineDavid Feldman, Terry S Elton, Doron M Menachemi, et al.
The Journal of Urology|August 12, 2005
Prostate specific antigen levels in young adulthood predict prostate cancer risk: results from a cohort of Black and White AmericansAlice S Whittemore, Piera M Cirillo, David Feldman, et al.
Clinical Cardiology|October 25, 2007
Management strategies for stage-D patients with acute heart failureDavid Feldman, Doron M Menachemi, William T Abraham, et al.
Pageof 22

Showing results (71-80 of 211) with videos related to

Sort By:
Pageof 22
Seminars in Dialysis|February 7, 2008
Indications for stent placement in a dialysis accessRandall L Rasmussen, David Feldman, Gerald Beathard, et al.
Nature|August 28, 2015
Water and climate: Recognize anthropogenic droughtAmir AghaKouchak, David Feldman, Martin Hoerling, et al.
International Journal of Radiation Oncology, Biology, Physics|September 2, 2008
Selenite treatment inhibits LAPC-4 tumor growth and prostate-specific antigen secretion in a xenograft model of human prostate cancerRumi S Bhattacharyya, Bryan Husbeck, David Feldman, et al.
Molecular and Cellular Endocrinology|June 16, 2005
Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activitySrilatha Swami, Aruna V Krishnan, Donna M Peehl, et al.
Bulletin of the Hospital for Joint Disease (2013)|August 24, 2014
Hip dysplasia in the skeletally mature patientRachel Y Goldstein, Ian David Kaye, James Slover, et al.
Anticancer Research|August 5, 2006
Mechanisms of vitamin D-mediated growth inhibition in prostate cancer cells: inhibition of the prostaglandin pathwayJacqueline Moreno, Aruna V Krishnan, Donna M Peehl, et al.
Molecular Cancer Therapeutics|August 25, 2006
Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of actionBryan Husbeck, Rumi S Bhattacharyya, David Feldman, et al.
Vascular Health and Risk Management|June 12, 2010
Heart rate control with adrenergic blockade: clinical outcomes in cardiovascular medicineDavid Feldman, Terry S Elton, Doron M Menachemi, et al.
The Journal of Urology|August 12, 2005
Prostate specific antigen levels in young adulthood predict prostate cancer risk: results from a cohort of Black and White AmericansAlice S Whittemore, Piera M Cirillo, David Feldman, et al.
Clinical Cardiology|October 25, 2007
Management strategies for stage-D patients with acute heart failureDavid Feldman, Doron M Menachemi, William T Abraham, et al.
Pageof 22